Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review

被引:0
作者
Erin Chung
Jonathan Sen
Priya Patel
Winnie Seto
机构
[1] The Hospital for Sick Children,Department of Pharmacy
[2] University of Toronto,Graduate Department of Pharmaceutical Sciences
[3] University of Melbourne,Faculty of Medicine, Dentistry and Health Sciences
来源
Clinical Pharmacokinetics | 2021年 / 60卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:985 / 1001
页数:16
相关论文
共 521 条
[1]  
Rossignoli A(2007)Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000–2005 Eur J Clin Pharmacol 63 1099-1106
[2]  
Clavenna A(2014)Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics Int J Antimicrob Agents 43 223-230
[3]  
Bonati M(2015)Pediatric vancomycin dosing: trends over time and the impact of therapeutic drug monitoring J Clin Pharmacol 55 212-220
[4]  
Downes KJ(2019)Vancomycin dosing, monitoring and toxicity: critical review of the clinical practice Clin Exp Pharmacol Physiol 46 292-301
[5]  
Hahn A(2020)Therapeutic monitoring of vancomycin for serious methicillin-resistant Clin Infect Dis 13 13-1706
[6]  
Wiles J(2004) infections: a revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists Ann Pharmacother. 38 1702-1003
[7]  
Courter JD(2007)Population pharmacokinetics I: background, concepts, and models Am J Geriatr Psychiatry. 14 993-94
[8]  
Vinks AA(2009)Population pharmacokinetics in geriatric psychiatry Ann Intern Med. 151 W65-546
[9]  
Balch AH(2020)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Mil Med Res 7 7-e571
[10]  
Constance JE(2020)Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Eur J Drug Metab Pharmacokinet 45 535-113